1.20 0.03 (2.56%)

76.05% Fall from 52W High

382.2K XNAS Volume

High vol.+gain this week

XNAS 19 Mar, 2025 4:01 PM (EDT)



Insider Trading disclosures for Mira Pharmaceuticals Inc

The latest disclosure was made by Matthew Pratt Whalen in Mira Pharmaceuticals Inc where a trade of 25,000 Stock Options (right to buy) done was reported to US exchanges on Dec. 9, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Matthew Pratt Whalen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 25,000 25,000 - - Stock Options (right to buy)
Ned MacPherson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 25,000 25,000 - - Stock Options (right to buy)
Denil Nanji Shekhat Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 50,000 50,000 - - Stock Options (right to buy)
Matthew Paul Del Giudice Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 25,000 75,000 - - Stock Options (right to buy)
Michelle Yanez Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 150,000 150,000 - - Stock Options (right to buy)
Erez Aminov Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 500,000 500,000 - - Restricted Stock Units
Erez Aminov Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 2,000,000 2,000,000 - - Stock Options (right to buy)
Aminov Erez Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 1.39 per share. 19 Nov 2024 55,410 1,105,790 - 1.4 77,020 Common Stock
Aminov Erez Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 1.27 per share. 19 Nov 2024 44,590 1,061,200 - 1.3 56,629 Common Stock
Denil Nanji Shekhat Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2024 50,000 41,666 - - Nonqualified Stock Option (right to buy)
Erez Aminov Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2024 379,000 629,000 - - Incentive Stock Options (right to buy)
Erez Aminov Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.85 per share. 21 May 2024 1,000 380,000 - 0.9 850 Common Stock
Erez Aminov Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.00 per share. 21 May 2024 2,000 375,500 - 1 2,000 Common Stock
Erez Aminov Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.01 per share. 21 May 2024 800 381,400 - 1.0 808 Common Stock
Erez Aminov Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.87 per share. 21 May 2024 600 380,600 - 0.9 522 Common Stock
Erez Aminov Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.84 per share. 21 May 2024 2,000 379,000 - 0.8 1,680 Common Stock
Erez Aminov Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.02 per share. 21 May 2024 500 377,000 - 1.0 510 Common Stock
Erez Aminov Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.03 per share. 21 May 2024 1,000 376,500 - 1.0 1,030 Common Stock
Erez Aminov Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.97 per share. 21 May 2024 800 382,200 - 1.0 776 Common Stock
Michelle Yanez Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2024 150,000 57,799 - - Incentive Stock Option (right to buy)
Erez Aminov Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Mar 2024 300,000 250,000 - - Incentive Stock Option (right to buy)
Ned MacPherson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 50,000 25,000 - - Nonqualified Stock Option (right to buy)
Denil N. Shekhat Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 50,000 25,000 - - Nonqualified Stock Option (right to buy)
Matthew P. Del Giudice Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 50,000 25,000 - - Nonqualified Stock Option (right to buy)
Michael Jerman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 50,000 25,000 - - Nonqualified Stock Option (right to buy)
Christopher C. Chapman Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2023 50,000 50,000 - - Stock Options
Christos Nicholoudis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2023 10,000 10,000 - - Stock Options
Michelle Yanez CFO, Secretary and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2023 20,000 20,000 - - Stock Options
Erez Aminov Director, CEO and Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2023 150,000 150,000 - - Stock Options
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures